Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ophtha.2020.10.036
PubMed Identifier: 33157077
Publication URI: http://europepmc.org/abstract/MED/33157077
Type: Journal Article/Review
Volume: 128
Parent Publication: Ophthalmology
Issue: 6
ISSN: 0161-6420